| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT05651880 Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory… |
date change Primary completion pushed: 2029-08 -> 2029-12 |
| 2026-06-09 | NCT05651880 Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory… |
date change Completion pushed: 2029-08 -> 2029-12 |
| 2026-05-27 | NCT05609630 Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in… |
Trial sites expanded: 44 -> 56 locations |
| 2026-05-27 | NCT05094128 A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-21 | NCT05723198 A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age… |
date change Completion pushed: 2030-02 -> 2033-09 |
| 2026-05-16 | NCT05094128 A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who… |
date change Primary completion pushed: 2026-06 -> 2027-04 |
| 2026-05-16 | NCT05094128 A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who… |
date change Completion pushed: 2026-06 -> 2027-04 |
| 2026-05-15 | NCT05782907 Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib… |
date change Completion moved earlier: 2033-10 -> 2031-10 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-27 | NCT07608796 JAK Signaling in Depression and Cognition in Male Football Players | Phase 2 | Not Yet Recruiting |
| 2026-05-19 | NCT07597577 Upadacitinib in Isolated Small Bowel Versus Non-Small Bowel Crohn's Disease | Completed | |
| 2026-05-15 | NCT07588568 A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07258771 | Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for… | Ulcerative Colitis Acute | Recruiting |
| NCT06454188 | A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients… | Psoriatic Arthritis | Recruiting |
| NCT07546097 | Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for… | Acute Severe Ulcerative Colitis | Recruiting |
| NCT07550673 | Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative… | Acute Severe Ulcerative Colitis | Recruiting |
| NCT07510191 | TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With… | Crohn Disease (CD) | Recruiting |
| NCT07357649 | Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis | Rheumatoid Arthritis | Not Yet Recruiting |
| NCT05300932 | A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis | Systemic Sclerosis | Active, Not Recruiting |
| NCT06240351 | A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal… | Frontal Fibrosing Alopecia | Active, Not Recruiting |
| NCT07018206 | Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients… | Axial Spondylarthritis (axSpA) | Not Yet Recruiting |
| NCT07502339 | Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis | UC - Ulcerative Colitis | Not Yet Recruiting |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT04088396 | A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old… | Systemic Juvenile Idiopathic Arthritis | Recruiting |
| NCT05889182 | A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in… | Hidradenitis Suppurativa | Recruiting |
| NCT06928272 | Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study | Long COVID | Recruiting |
| NCT06461897 | A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral… | Atopic Dermatitis | Recruiting |
| NCT04381936 | Randomised Evaluation of COVID-19 Therapy | Pneumonia | Recruiting |
| NCT06631287 | Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent… | Long COVID | Recruiting |
| NCT03773965 | A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With… | Juvenile Idiopathic Arthritis | Recruiting |
| NCT06012240 | A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… | Alopecia Areata | Recruiting |
| NCT05723198 | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age… | Areata Alopecia | Recruiting |
| NCT06389136 | A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis… | Atopic Dermatitis | Recruiting |
| NCT05609630 | Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in… | Juvenile Idiopathic Arthritis | Recruiting |
| NCT06227910 | A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease | Crohn's Disease | Recruiting |
| NCT04972760 | Baricitinib in Patients With Relapsing or naïve Dermatomyositis | Dermatomyositis | Recruiting |
| NCT06332534 | Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric… | Crohn's Disease | Recruiting |